ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 797,95
1,46%
DAX
18 518,03
-0,44%
Brent Oil
83,54
-0,95%
Bitcoin
64 470,51
-0,59%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
26/01/201521h23Business WireTeva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
26/01/201514h10Dow Jones NewsFDA Rejects Antares' Application for Generic Migraine DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
21/01/201500h03Dow Jones NewsADR Shares End Mixed; SAP Shares FallNYSE:TEVATeva Pharmaceutical Industries Ltd.
20/01/201523h13Dow Jones NewsSupreme Court Sides With Teva in Patent Case on Copaxone -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
20/01/201518h59Dow Jones NewsSupreme Court Sides With Teva in Patent Case on Copaxone -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
20/01/201517h41Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
20/01/201517h25Business WireTeva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case & Remand...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/01/201517h02Dow Jones NewsSupreme Court Sides With Teva in Patent Case on CopaxoneNYSE:TEVATeva Pharmaceutical Industries Ltd
15/01/201518h57Business WireTeva to Report Fourth Quarter 2014 Financial Results on February 5, 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/201514h00GlobeNewswire Inc.Xenon Pharmaceuticals Outlines Key Anticipated Milestones for 2015NYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/201514h00Business WireTeva to Present at the 33rd Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
06/01/201523h40Business WireTeva Launches Generic Diovan® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
30/12/201413h00PR Newswire (US)OncoGenex to Regain Rights to Custirsen from TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
23/12/201414h00Business WireFDA Approves Teva’s GRANIX® (tbo-filgrastim) Injection for Self-AdministrationNYSE:TEVATeva Pharmaceutical Industries Ltd
22/12/201414h00Business WireTeva to Present at the Goldman Sachs Healthcare CEOs Unscripted ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
19/12/201414h00Business WireTeva Announces FDA Approval of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol for Treatment of Children with Seasonal & ...NYSE:TEVATeva Pharmaceutical Industries Ltd
11/12/201415h58Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd.
11/12/201413h00Business WireTeva Provides 2015 Business OutlookNYSE:TEVATeva Pharmaceutical Industries Ltd
10/12/201414h30Business WireTeva Announces Launch of First Generic Celebrex® Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/12/201416h29Business WireTeva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of...NYSE:TEVATeva Pharmaceutical Industries Ltd
01/12/201421h46Business WireTeva to Host 2015 Business Outlook Conference Call and Webcast on December 11, 2014NYSE:TEVATeva Pharmaceutical Industries Ltd
01/12/201417h50Business WireTeva Announces Launch of Generic Exforge HCT® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
26/11/201417h13Business WireProf. Yitzhak Peterburg Elected Chairman of Teva’s Board of DirectorsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/11/201414h00Business WireTeva Launches Liquid Formulation of TREANDA® (bendamustine HCI) Injection in U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201414h00Business WireTeva Presents Data for Investigational Short-Acting Beta-Agonist Inhaler (Albuterol MDPI) at 2014 Annual Scientific Meeting o...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/11/201414h00Business WireTeva Presents Positive Safety & Efficacy Data for QNASL® (Beclomethasone Dipropionate) Nasal Aerosol in Treating Children wi...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/11/201414h00Business WireTeva & Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Mul...NYSE:TEVATeva Pharmaceutical Industries Ltd
30/10/201412h03Business WireTeva Reports Third Quarter 2014 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
08/10/201414h00Business WireTeva Announces Initiation of New Drug Application & Positive Results from Second Human Abuse Liability Study for CEP-33237 (H...NYSE:TEVATeva Pharmaceutical Industries Ltd
06/10/201419h59Business WireTeva to Report Third Quarter 2014 Financial Results on October 30, 2014NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

USOTC
WKGBF
Sanderson Design (PK)
NYSE
DCN
Dana
LSE
0MWL
Vaneck Vectors Ucits Etfs
COIN
SHIBUSD
SHIBA INU
TSXV
GBR
Great Bear Resources
NASDAQ
BRKR
Bruker
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés